Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""COVID-19 Vaccines"" wg kryterium: Temat


Tytuł:
Predictors of COVID-19 vaccine uptake: an online three-wave survey study of US adults.
Autorzy:
Thorpe A; Department of Population Health Sciences, Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, USA. .; Department of Applied Health Research, University College London, London, UK. .
Fagerlin A; Department of Population Health Sciences, Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, USA.; Salt Lake City VA Informatics Decision- Enhancement and Analytic Sciences (IDEAS) Center for Innovation, Salt Lake City, UT, USA.
Drews FA; Salt Lake City VA Informatics Decision- Enhancement and Analytic Sciences (IDEAS) Center for Innovation, Salt Lake City, UT, USA.; University of Utah College of Social and Behavioral Science, Salt Lake City, UT, USA.
Shoemaker H; Department of Population Health Sciences, Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, USA.; Salt Lake City VA Informatics Decision- Enhancement and Analytic Sciences (IDEAS) Center for Innovation, Salt Lake City, UT, USA.
Brecha FS; Department of Population Health Sciences, Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, USA.; Department of Pediatrics, Columbia University, New York, NY, USA.
Scherer LD; Division of Cardiology, University of Colorado, School of Medicine, Aurora, CO, USA.; Denver VA Center of Innovation, Denver, CO, USA.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 12; Vol. 24 (1), pp. 304. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Vaccines*
COVID-19*
Adult ; Humans ; Eligibility Determination ; Health Facilities ; Logistic Models ; Vaccination
Czasopismo naukowe
Tytuł:
Safety of a mRNA COVID-19 Vaccine in Patients with Indolent Systemic Mastocytosis.
Autorzy:
Gouveia J; Serviço de Imunoalergologia. Centro Hospitalar Universitário de Santo António. Porto. Portugal.
Rodrigues MA; Serviço de Dermatologia. Centro Hospitalar Universitário de Santo António. Porto. Portugal.
Fernandes I; Serviço de Dermatologia. Centro Hospitalar Universitário de Santo António. Porto; Consulta Multidisciplinar de Linfomas Cutâneos e Mastocitoses. Centro Hospitalar Universitário de Santo António. Porto; Unidade Multidisciplinar de Investigação Biomédica. Instituto de Ciências Biomédicas Abel Salazar. Universidade do Porto. Porto. Portugal.
Cabral R; Serviço de Imunoalergologia. Centro Hospitalar Universitário de Santo António. Porto. Portugal.
Falcão H; Serviço de Imunoalergologia. Centro Hospitalar Universitário de Santo António. Porto. Portugal.
Pokaż więcej
Źródło:
Acta medica portuguesa [Acta Med Port] 2024 Mar 01; Vol. 37 (3), pp. 224-225. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Letter
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*/administration & dosage
Mastocytosis, Systemic*/complications
Humans
Opinia redakcyjna
Tytuł:
Social network risk factors and COVID-19 vaccination: A cross-sectional survey study.
Autorzy:
Memedovich A; Department of Community Health Sciences, Cumming School of Medicine and O'Brien Institute of Public Health, University of Calgary, Calgary, AB, Canada.
Orr T; Department of Community Health Sciences, Cumming School of Medicine and O'Brien Institute of Public Health, University of Calgary, Calgary, AB, Canada.
Hollis A; Department of Economics, University of Calgary, 2500 University Dr. NW, Calgary, AB, Canada.
Salmon C; Department of Community Health Sciences, Cumming School of Medicine and O'Brien Institute of Public Health, University of Calgary, Calgary, AB, Canada.
Hu J; Department of Community Health Sciences, Cumming School of Medicine and O'Brien Institute of Public Health, University of Calgary, Calgary, AB, Canada.
Zinszer K; Department of Social and Preventive Medicine, Université de Montréal, Montréal, QC, Canada; Centre for Public Health Research, University of Montreal, Canada.
Williamson T; Department of Community Health Sciences, Cumming School of Medicine and O'Brien Institute of Public Health, University of Calgary, Calgary, AB, Canada.
Beall RF; Department of Community Health Sciences, Cumming School of Medicine and O'Brien Institute of Public Health, University of Calgary, Calgary, AB, Canada. Electronic address: .
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2024 Feb 06; Vol. 42 (4), pp. 891-911. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Vaccines*/therapeutic use
COVID-19*/epidemiology
COVID-19*/prevention & control
North American People*
Humans ; Cross-Sectional Studies ; Canada/epidemiology ; Vaccination ; Social Networking ; Risk Factors
Czasopismo naukowe
Tytuł:
Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques.
Autorzy:
McMahan K; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Wegmann F; Janssen Vaccines and Prevention, Leiden, Netherlands.
Aid M; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Sciacca M; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Liu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Hachmann NP; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Miller J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Jacob-Dolan C; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Powers O; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Hope D; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Wu C; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Pereira J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Murdza T; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Mazurek CR; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Hoyt A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Boon ACM; Washington University School of Medicine, St Louis, MO, USA.
Davis-Gardner M; Emory School of Medicine, Atlanta, GA, USA.
Suthar MS; Emory School of Medicine, Atlanta, GA, USA.
Martinot AJ; Tufts University Cummings School of Veterinary Medicine, Grafton, MA, USA.
Boursiquot M; Bioqual, Rockville, MD, USA.
Cook A; Bioqual, Rockville, MD, USA.
Pessaint L; Bioqual, Rockville, MD, USA.
Lewis MG; Bioqual, Rockville, MD, USA.
Andersen H; Bioqual, Rockville, MD, USA.
Tolboom J; Janssen Vaccines and Prevention, Leiden, Netherlands.
Serroyen J; Janssen Vaccines and Prevention, Leiden, Netherlands.
Solforosi L; Janssen Vaccines and Prevention, Leiden, Netherlands.
Costes LMM; Janssen Vaccines and Prevention, Leiden, Netherlands.
Zahn RC; Janssen Vaccines and Prevention, Leiden, Netherlands.
Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA. .; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA. .
Pokaż więcej
Źródło:
Nature [Nature] 2024 Feb; Vol. 626 (7998), pp. 385-391. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
COVID-19*/immunology
COVID-19*/prevention & control
COVID-19*/virology
COVID-19 Vaccines*/administration & dosage
COVID-19 Vaccines*/immunology
Immunity, Mucosal*/immunology
Immunization, Secondary*/methods
Macaca mulatta*/immunology
Macaca mulatta*/virology
SARS-CoV-2*/classification
SARS-CoV-2*/immunology
Animals ; Humans ; Administration, Intranasal ; Antibodies, Neutralizing/biosynthesis ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/biosynthesis ; Antibodies, Viral/immunology ; CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/immunology ; Cytokines/immunology ; Immunoglobulin A/immunology ; Immunoglobulin G/immunology ; Injections, Intramuscular ; Killer Cells, Natural/immunology ; Lung/immunology ; mRNA Vaccines/administration & dosage ; mRNA Vaccines/immunology ; Trachea/immunology ; Trachea/virology
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
How the case counting window affected vaccine efficacy calculations in randomized trials of COVID-19 vaccines.
Autorzy:
Doshi P; Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
Fung K; Numbersense, Inc, New York, New York, USA.
Pokaż więcej
Źródło:
Journal of evaluation in clinical practice [J Eval Clin Pract] 2024 Feb; Vol. 30 (1), pp. 105-106. Date of Electronic Publication: 2023 Jul 15.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Vaccines*
COVID-19*/epidemiology
COVID-19*/prevention & control
Humans ; Vaccine Efficacy ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Menstrual Changes Following COVID-19 Vaccination: A Cross-Sectional Study.
Autorzy:
Fallatah NI; Academy of Family Medicine, Ministry of Health, Madinah 42313, Saudi Arabia.
Alrehaili BO; Madinah Health Cluster, Ministry of Health, Madinah 42351, Saudi Arabia.
Alsulami SS; Faculty of Medicine Rabigh, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Al-Zalabani AH; Department of Family and Community Medicine, College of Medicine, Taibah University, Madinah 42353, Saudi Arabia.
Pokaż więcej
Źródło:
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2024 Jan 25; Vol. 60 (2). Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
Menorrhagia*
Adult ; Female ; Humans ; Young Adult ; Cross-Sectional Studies ; Menstruation ; Vaccination
Czasopismo naukowe
Tytuł:
Comparison of adult hesitancy towards COVID-19 vaccines and vaccines in general in the USA.
Autorzy:
Nguyen KH; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Coy KC; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA; Leidos Inc., Atlanta, GA, USA.
Black CL; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Scanlon P; National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD, USA.
Singleton JA; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: .
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2024 Jan 25; Vol. 42 (3), pp. 645-652. Date of Electronic Publication: 2023 Dec 23.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*
Vaccination Hesitancy*
Adult ; Humans ; United States
Czasopismo naukowe
Tytuł:
Effectiveness of COVID-19 vaccine mandates in raising vaccination rates among the elderly and general population in Europe: Controlled interrupted time series analysis.
Autorzy:
Lytras T; School of Medicine, European University Cyprus, Nicosia, Cyprus. Electronic address: .
Di Gregorio AAA; School of Medicine, European University Cyprus, Nicosia, Cyprus.
Apostolopoulos D; School of Medicine, European University Cyprus, Nicosia, Cyprus.
Naziris D; School of Medicine, European University Cyprus, Nicosia, Cyprus.
Zingerle C; School of Medicine, European University Cyprus, Nicosia, Cyprus.
Heraclides A; School of Sciences, European University Cyprus, Nicosia, Cyprus.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2024 Jan 12; Vol. 42 (2), pp. 156-161. Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Vaccines*
COVID-19*/epidemiology
COVID-19*/prevention & control
Adult ; Humans ; Aged ; Middle Aged ; Interrupted Time Series Analysis ; Mandatory Vaccination ; Pandemics ; Mandatory Programs ; Europe/epidemiology ; Vaccination
Czasopismo naukowe
Tytuł:
Otorhinolaryngologic complications after COVID-19 vaccination, vaccine adverse event reporting system (VAERS).
Autorzy:
Shin J; Department of Biomedical Informatics, College of Medicine, Konyang University, Daejeon, Republic of Korea.; Konyang Medical data Research group-KYMERA, Konyang University Hospital, Daejeon, Republic of Korea.
Shim SR; Department of Biomedical Informatics, College of Medicine, Konyang University, Daejeon, Republic of Korea.; Konyang Medical data Research group-KYMERA, Konyang University Hospital, Daejeon, Republic of Korea.
Lee J; Department of Emergency Medicine, College of Medicine, Konyang University Hospital, Daejeon, Republic of Korea.
Ryu HS; Department of Emergency Medicine, College of Medicine, Konyang University Hospital, Daejeon, Republic of Korea.
Kim JY; Department of Biomedical Informatics, College of Medicine, Konyang University, Daejeon, Republic of Korea.; Konyang Medical data Research group-KYMERA, Konyang University Hospital, Daejeon, Republic of Korea.; Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Konyang University Hospital, Daejeon, Republic of Korea.
Pokaż więcej
Źródło:
Frontiers in public health [Front Public Health] 2024 Jan 10; Vol. 11, pp. 1338862. Date of Electronic Publication: 2024 Jan 10 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Anosmia*/etiology
COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
Tinnitus*/etiology
Female ; Humans ; Male ; Adverse Drug Reaction Reporting Systems ; United States/epidemiology ; Vaccination/adverse effects
Czasopismo naukowe
Tytuł:
Immunogenicity, clinical efficacy and safety of additional second COVID-19 booster vaccines against Omicron and its subvariants: A systematic review.
Autorzy:
Chenchula S; All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Chandra MB; All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Adusumilli MB; All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Ghanta SN; University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Bommasani A; Chirayu Medical College, Bhopal, Madhya Pradesh, India.
Kuttiappan A; School of Pharmacy and Technology Management, SVKM'S NMIMS, Shirpur, Maharashtra, India.
Padmavathi R; SVS Medical College and Hospital, Mahbubnagar, Telangana, India.
Amerneni KC; Western Michigan University, Kalamazoo, Michigan, USA.
Chikatipalli R; Sri Venkateshwara College of Pharmacy, Chittoor, Andhra Pradesh, India.
Ghanta MK; MVJ Medical College and Research Hospital, Bangalore, Karnataka, India.
Reddy SS; All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Mythili Bai K; Siddhartha Medical College, Vijayawada, Andhra Pradesh, India.
Prakash S; All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Jogender G; All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Chavan M; All India Institute of Medical Sciences, Mangalagiri, Andhra Pradesh, India.
Balakrishnan S; All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Pokaż więcej
Źródło:
Reviews in medical virology [Rev Med Virol] 2024 Jan; Vol. 34 (1), pp. e2515.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*/therapeutic use
Humans ; mRNA Vaccines ; SARS-CoV-2 ; Treatment Outcome
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Safety and efficacy of COVID-19 vaccines: A systematic review and meta-analysis of controlled and randomized clinical trials.
Autorzy:
Beladiya J; Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India.
Kumar A; Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India.
Vasava Y; Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India.
Parmar K; Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India.
Patel D; Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India.
Patel S; Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India.
Dholakia S; Department of Pharmaceutical Chemistry, L. M. College of Pharmacy, Ahmedabad, Gujarat, India.
Sheth D; Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India.
Boddu SHS; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, UAE.; Center of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, UAE.
Patel C; Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India.
Pokaż więcej
Źródło:
Reviews in medical virology [Rev Med Virol] 2024 Jan; Vol. 34 (1), pp. e2507.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
COVID-19 Vaccines*/therapeutic use
Humans ; Randomized Controlled Trials as Topic ; SARS-CoV-2 ; Vaccines, Inactivated/adverse effects
Czasopismo naukowe
Tytuł:
Heterologous COVID-19 vaccines intervention effect on reactogenicity.
Autorzy:
Najeeb W; Pakistan Institute of Medical Sciences, Islamabad, Pakistan.
Waheed P; Army Medical College, National University of Medical Sciences, Rawalpindi, Pakistan.
Khadim R; Army Medical College, Rawalpindi, Pakistan.
Pokaż więcej
Źródło:
JPMA. The Journal of the Pakistan Medical Association [J Pak Med Assoc] 2024 Jan; Vol. 74 (1), pp. 134-137.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
Humans ; 2019-nCoV Vaccine mRNA-1273 ; Antibodies, Viral ; Dizziness ; Myalgia
Czasopismo naukowe
Tytuł:
Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data.
Autorzy:
Li Y; McWilliams School of Biomedical Informatics, the University of Texas Health Science Center at Houston, Houston, TX, USA.
Lundin SK; McWilliams School of Biomedical Informatics, the University of Texas Health Science Center at Houston, Houston, TX, USA.; Department of Biostatistics & Data Science, School of Public Health, the University of Texas Health Science Center at Houston, Houston, TX, USA.
Li J; McWilliams School of Biomedical Informatics, the University of Texas Health Science Center at Houston, Houston, TX, USA.; Department of Artificial Intelligence and Informatics, Mayo Clinic, Jacksonville, FL, USA.
Tao W; Department of Biostatistics & Data Science, School of Public Health, the University of Texas Health Science Center at Houston, Houston, TX, USA.
Dang Y; McWilliams School of Biomedical Informatics, the University of Texas Health Science Center at Houston, Houston, TX, USA.
Chen Y; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Tao C; McWilliams School of Biomedical Informatics, the University of Texas Health Science Center at Houston, Houston, TX, USA.; Department of Artificial Intelligence and Informatics, Mayo Clinic, Jacksonville, FL, USA.
Pokaż więcej
Źródło:
Expert review of vaccines [Expert Rev Vaccines] 2024 Jan-Dec; Vol. 23 (1), pp. 53-59. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
Vaccines*/adverse effects
Aged ; Female ; Humans ; Male ; Pregnancy ; Adverse Drug Reaction Reporting Systems ; United States ; Vaccination/adverse effects
Czasopismo naukowe
Tytuł:
Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond.
Autorzy:
Chen S; ARC Centre of Excellence in Population Ageing Research (CEPAR), University of New South Wales, Sydney, Australia.; School of Risk and Actuarial Studies, University of New South Wales, Sydney, Australia.
Rodewald LE; Department of the National Immunization Program, Chinese Center for Disease Control and Prevention, National Immunization Program, China CDC, Beijing, China.
Du AH; China Country Office, Bill & Melinda Gates Foundation, Beijing, China.
Tang S; Duke Global Health Institute, Duke University, Durham, NC, USA. .; Global Health Research Center, Duke Kunshan University, No. 8 Duke Avenue, Kunshan, 215316, Jiangsu, China. .; SingHealth Duke-NUS Global Health Institute, Duke-NUS, Singapore, Singapore. .
Pokaż więcej
Źródło:
Infectious diseases of poverty [Infect Dis Poverty] 2024 Mar 13; Vol. 13 (1), pp. 25. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Editorial
MeSH Terms:
COVID-19 Vaccines*
Vaccines*
Child ; Humans ; Vaccination ; Immunization Programs ; China
Opinia redakcyjna
Tytuł:
Letter to the Editor Regarding "Antibody Production after COVID-19 Vaccination in Patients with Inborn Errors of Immunity".
Autorzy:
Deshpande N; Central Research Facility, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune (Deemed to be University), Sant Tukaram Nagar, Pune, 411018, Maharashtra, India.
Pokaż więcej
Źródło:
Iranian journal of immunology : IJI [Iran J Immunol] 2024 Mar 12; Vol. 21 (1), pp. 101-102. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Letter
MeSH Terms:
COVID-19 Vaccines*
COVID-19*
Humans ; Antibody Formation ; Vaccination ; Antibodies, Viral
Opinia redakcyjna
Tytuł:
Fourth dose of microneedle array patch of SARS-CoV-2 S1 protein subunit vaccine elicits robust long-lasting humoral responses in mice.
Autorzy:
Kim E; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Shin J; Medical Business Division, Raphas Co., Ltd., Seoul, Republic of Korea.
Ferrari A; Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico San Matteo, Pavia, Italy.
Huang S; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
An E; Medical Business Division, Raphas Co., Ltd., Seoul, Republic of Korea.
Han D; Medical Business Division, Raphas Co., Ltd., Seoul, Republic of Korea.
Khan MS; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Infectious Diseases and Microbiology, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA.
Kenniston TW; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Cassaniti I; Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico San Matteo, Pavia, Italy.
Baldanti F; Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico San Matteo, Pavia, Italy; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
Jeong D; Medical Business Division, Raphas Co., Ltd., Seoul, Republic of Korea.
Gambotto A; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Infectious Diseases and Microbiology, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; UPMC Hillman Cancer Center, Pittsburgh, PA, USA. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2024 Mar 10; Vol. 129, pp. 111569. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Vaccines*
COVID-19*/prevention & control
Animals ; Humans ; Mice ; Protein Subunits ; SARS-CoV-2 ; Protein Subunit Vaccines ; Pandemics ; Antibodies, Neutralizing ; Immunoglobulin G ; Antibodies, Viral
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Effectiveness of COVID-19 vaccines among children 6-11 years against hospitalization during Omicron predominance in Malaysia.
Autorzy:
Jayaraj VJ; Sector for Biostatistics & Data Repository, National Institutes of Health, Ministry of Health Malaysia, Selangor, Malaysia. .
Husin M; Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Selangor, Malaysia.
Suah JL; Data, Analytics and Research, Central Bank of Malaysia, Kuala Lumpur, Malaysia.
Tok PSK; Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Selangor, Malaysia.
Omar A; Sector for Biostatistics & Data Repository, National Institutes of Health, Ministry of Health Malaysia, Selangor, Malaysia.
Rampal S; Department of Social and Preventive Medicine, Faculty of Medicine, Centre for Epidemiology and Evidence-Based Practice, Universiti Malaya, Kuala Lumpur, Malaysia.
Sivasampu S; Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Selangor, Malaysia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 08; Vol. 14 (1), pp. 5690. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Vaccines*/therapeutic use
COVID-19*/epidemiology
COVID-19*/prevention & control
Child ; Humans ; BNT162 Vaccine ; Malaysia/epidemiology ; Hospitalization ; RNA, Messenger
Czasopismo naukowe
Tytuł:
The impact of policy and policy communication on COVID-19 vaccination inequalities among Venezuelan refugees and migrants in Colombia: a comparative cross-sectional interrupted time-series analysis.
Autorzy:
Gomez W; Center for Public Health and Human Rights, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Fernández-Niño JA; Center for Humanitarian Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Guillén JR; Red Somos, Bogotá, Colombia.
Stevenson M; Center for Public Health and Human Rights, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ortíz J; Red Somos, Bogotá, Colombia.
Barriga Talero MÁ; Red Somos, Bogotá, Colombia.
López JJ; Red Somos, Bogotá, Colombia.
Núñez RL; Government of Colombia Ministry of Health and Social Protection, Bogotá, Colombia.
Spiegel P; Center for Humanitarian Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Page KR; Center for Public Health and Human Rights, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Center for Humanitarian Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Medicine, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ramirez Correa JF; Red Somos, Bogotá, Colombia.
Porras DM; Red Somos, Bogotá, Colombia.
Wirtz AL; Center for Public Health and Human Rights, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA .; Center for Humanitarian Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
BMJ global health [BMJ Glob Health] 2024 Mar 07; Vol. 9 (3). Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*
Refugees*
South American People*
Transients and Migrants*
Adult ; Humans ; Colombia/epidemiology ; Communication ; Cross-Sectional Studies ; Health Policy ; Pandemics ; Vaccination
Czasopismo naukowe
Tytuł:
Influence of nutritional supplements on antibody levels in pregnant women vaccinated with inactivated SARS-CoV-2 vaccines.
Autorzy:
Zhang X; Department of Occupational and Environmental Health, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, Guangdong Province, China.
Han X; Department of Occupational and Environmental Health, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, Guangdong Province, China.
Chen B; Department of Occupational and Environmental Health, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, Guangdong Province, China.
Fu X; Department of Occupational and Environmental Health, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, Guangdong Province, China.
Gong Y; Department of Epidemiology and Medical Statistics, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, Guangdong Province, China.
Yang W; Department of Child and Adolescent Health, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, Guangdong Province, China.
Chen Q; Department of Occupational and Environmental Health, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, Guangdong Province, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 07; Vol. 19 (3), pp. e0289255. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
COVID-19 Vaccines*
COVID-19*/prevention & control
Pregnancy ; Female ; Humans ; Pregnant Women ; Cross-Sectional Studies ; SARS-CoV-2 ; Dietary Supplements ; Folic Acid ; Iron ; Antibodies, Neutralizing ; Immunoglobulin G ; Antibodies, Viral ; Vaccines, Inactivated
Czasopismo naukowe
Tytuł:
Minimal change disease following COVID-19 vaccination: A systematic review.
Autorzy:
Kechagias KS; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom.
Laleye JD; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom.
Drmota J; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom.
Geropoulos G; Western General Hospital, Lothian NHS, Edinburgh, United Kingdom.
Kyrtsonis G; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom.
Zafeiri M; School of Cardiovascular Medicine and Sciences, King's College London, London, United Kingdom.
Triantafyllidis KK; Department of Nutrition and Dietetics, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Stathi D; Department of Endocrinology and Diabetes, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 05; Vol. 19 (3), pp. e0297568. Date of Electronic Publication: 2024 Mar 05 (Print Publication: 2024).
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
Nephrosis, Lipoid*/chemically induced
Humans ; Recurrence ; Vaccination/adverse effects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies